21 results
8-K
EX-99.2
COGT
Cogent Biosciences Inc
12 Dec 22
Cogent Biosciences Announces Positive Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating
8:03am
):5727-5736. 5AYVAKIT (avapritinib) [package insert]. Blueprint Medicines Corporation; 5 2021. 6Magliacane D et al., Transl Med UniSa. 2014;8:65-74 … . 7RYDAPT (midostaurin) [package insert]. Novartis Pharmaceuticals; 2021.
1 Systemic Mastocytosis: Estimated prevalence in the U.S. is 20,000–30,000
424B5
r2riu
2 Dec 20
Prospectus supplement for primary offering
5:06pm
424B5
2uhlli8p2
30 Nov 20
Prospectus supplement for primary offering
5:28pm
DEF 14A
ebivx24ifs
30 Apr 19
Definitive proxy
5:25pm